All Recalls

95,114 total recalls in our database

Dexamethasone (pf) 0.05 % opth.

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

Dexamethosone/Tobramycin pf 0.1%/0.3% ophthalmic

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

CGMP Deviations: Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII, 10 mg were manufactured using unapproved material: the finished product was not properly quarantined as rejected due to inadequate cleaning of equipment.

Jan 24, 2014 Prescription Drugs Nationwide View Details →

Marketed without an Approved NDA/ANDA; product found to contain methasterone and dimethazine which are steroid and/or steroid-like drug ingredients, making it an unapproved new drug

Jul 22, 2013 Prescription Drugs Nationwide View Details →

Novarel (IM)

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

EDTA 3% ophthalmic

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

Bleomycin Sulfate 1unit/ml

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

Voriconazole 0.5mg/ml

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

Methotrexate Intraocular 400mcg 0.1cc

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

Presence of Precipitate: Recall is due to complaints of a white substance, confirmed as Guaifenesin, an active ingredient in the product which is precipitating out.

Feb 4, 2014 Over-the-Counter Nationwide View Details →

Microbial Contamination of Non-Sterile Products: Out-of-specification results for microbial count were observed at the initial stability interval for Lansoprazole Delayed Release Capsules.

Jan 3, 2014 Prescription Drugs Nationwide View Details →

Tacrolimus 0.02% opth. (H20-based)

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

Vit A (olive oil) 0.1% opth.

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

Folic acid (pf) 10mg/cc inj

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

Triamcinolone Acetonide 3mg/ml

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

Tacrolimus (H20-based) 0.03% ophth.

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →

Voriconazole 1% opthal

Natures Pharmacy & Compounding Center

💊 Drugs Class I - Dangerous

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Nov 1, 2013 Other Drugs View Details →